Dr. Reddy's Laboratories
RDY
#1703
Rank
C$16.50 B
Marketcap
C$19.73
Share price
0.07%
Change (1 day)
-0.65%
Change (1 year)

Dr. Reddy's Laboratories (RDY) - Total debt

Total debt on the balance sheet as of September 2025 : C$0.91 Billion

According to Dr. Reddy's Laboratories's latest financial reports the company's total debt is C$0.91 Billion. A companyโ€™s total debt is the sum of all current and non-current debts.

Dr. Reddy's Laboratories - Total debt on balance sheet (from 2001 to 2025)

Total debt by year

Year Total debt Change
2025-03-31C$0.78 B142.49%
2024-03-31C$0.32 B46.38%
2023-03-31C$0.22 B-60.19%
2022-03-31C$0.55 B7.13%
2021-03-31C$0.52 B25.93%
2020-03-31C$0.41 B-44.01%
2019-03-31C$0.73 B-26.53%
2018-03-31C$1.00 B-0.49%
2017-03-31C$1.00 B53.57%
2016-03-31C$0.65 B-25.17%
2015-03-31C$0.87 B6.54%
2014-03-31C$0.82 B19.67%
2013-03-31C$0.68 B8.89%
2012-03-31C$0.63 B23.02%
2011-03-31C$0.51 B54.28%
2010-03-31C$0.33 B-32.02%
2009-03-31C$0.49 B0.1%
2008-03-31C$0.48 B-26.37%
2007-03-31C$0.66 B-18.42%
2006-03-31C$0.81 B933.75%
2005-03-31C$78.88 M417.84%
2004-03-31C$15.23 M49.43%
2003-03-31C$10.19 M104.4%
2002-03-31C$4.98 M-96.26%
2001-03-31C$0.13 B

Total debt for similar companies or competitors

Company Total debt/th> differencediff. Country
Pfizer
PFE
C$84.89 B 9,134.49%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
C$23.82 B 2,491.05%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
GlaxoSmithKline
GSK
C$33.29 B 3,521.37%๐Ÿ‡ฌ๐Ÿ‡ง UK
Novartis
NVS
C$44.67 B 4,759.76%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Sanofi
SNY
C$35.62 B 3,774.71%๐Ÿ‡ซ๐Ÿ‡ท France